2016-02-24T16:18:00
Flu vaccine provider Seqirus is to develop a £15.3m production facility at its manufacturing plant in Liverpool as part of a planned expansion of activity at the site.
You must be logged in to continue
Try Property Week For Free to finish this article.
Sign up now for the following benefits:
To access this article TRY FOR FREE NOW
Don’t want full access? REGISTER NOW to read this article and up to 3 more this month and subscribe to our newsletters.
Registered users and subscribers SIGN IN here to continue
Site powered by Webvision Cloud